MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
CMMB Chemomab Therapeutics
- 1.680
- +0.060+3.70%
Close Dec 20 16:00 ET
31.68MMarket Cap-1.79P/E (TTM)
1.680High1.607Low40.23KVolume1.620Open1.620Pre Close65.78KTurnover0.34%Turnover RatioLossP/E (Static)18.86MShares2.55052wk High1.94P/B19.86MFloat Cap0.45052wk Low--Dividend TTM11.82MShs Float184.000Historical High--Div YieldTTM4.49%Amplitude0.420Historical Low1.635Avg Price1Lot Size
Chemomab Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | --19.38M | -52.13%12.73M | -51.46%15.88M | -50.41%19.78M | -50.41%19.78M | -48.59%26.59M | -43.03%32.71M | -34.77%39.89M | -34.77%39.89M | -27.70%46.47M |
| -Cash and cash equivalents | --6.6M | -51.49%5.04M | -77.53%4.67M | -31.27%9.29M | -31.27%9.29M | 5.05%10.38M | 50.18%20.77M | -10.98%13.52M | -10.98%13.52M | -71.54%10.74M |
| -Short-term investments | --12.78M | -52.55%7.69M | -6.11%11.21M | -60.22%10.49M | -60.22%10.49M | -61.27%16.21M | -72.60%11.94M | -42.63%26.37M | -42.63%26.37M | 34.69%35.73M |
| Receivables | --439K | -37.24%654K | -11.06%885K | -37.04%289K | -37.04%289K | -66.45%1.04M | -48.55%995K | 156.42%459K | 156.42%459K | 43.52%2.26M |
| -Other receivables | --439K | -37.24%654K | -11.06%885K | -37.04%289K | -37.04%289K | -66.45%1.04M | -48.55%995K | 156.42%459K | 156.42%459K | 43.52%2.26M |
| Prepaid assets | ---- | ---- | ---- | -42.77%748K | -42.77%748K | ---- | ---- | -3.04%1.31M | -3.04%1.31M | ---- |
| Restricted cash | --75K | 0.00%74K | -2.60%75K | -1.30%76K | -1.30%76K | --74K | --77K | --77K | --77K | ---- |
| Total current assets | --19.89M | -51.43%13.46M | -50.15%16.84M | -49.93%20.9M | -49.93%20.9M | -49.47%27.71M | -43.08%33.78M | -33.42%41.74M | -33.42%41.74M | -26.00%48.73M |
| Non current assets | ||||||||||
| Net PPE | --577K | 23.90%617K | 20.37%656K | 17.00%695K | 17.00%695K | -23.38%498K | -18.29%545K | -15.38%594K | -15.38%594K | 8.09%641K |
| -Gross PPE | --577K | 23.90%617K | 20.37%656K | 21.34%921K | 21.34%921K | -23.38%498K | -18.29%545K | -6.18%759K | -6.18%759K | 8.09%641K |
| -Accumulated depreciation | ---- | ---- | ---- | -36.97%-226K | -36.97%-226K | ---- | ---- | -54.21%-165K | -54.21%-165K | ---- |
| Non current prepaid assets | --428K | -26.93%472K | -25.22%516K | -23.74%559K | -23.74%559K | -21.32%646K | -20.14%690K | -19.27%733K | -19.27%733K | -18.49%776K |
| Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 45.28%77K |
| Total non current assets | --1.01M | -4.81%1.09M | -5.10%1.17M | -5.50%1.25M | -5.50%1.25M | -26.10%1.14M | -23.58%1.24M | -20.30%1.33M | -20.30%1.33M | -6.51%1.49M |
| Total assets | --20.9M | -49.59%14.54M | -48.56%18.01M | -48.56%22.15M | -48.56%22.15M | -48.83%28.85M | -42.56%35.01M | -33.08%43.06M | -33.08%43.06M | -25.54%50.22M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | --386K | -52.58%1.11M | -76.23%527K | -69.43%516K | -69.43%516K | 63.78%2.35M | 49.09%2.22M | 26.35%1.69M | 26.35%1.69M | 159.25%1.25M |
| -accounts payable | --386K | -52.58%1.11M | -76.23%527K | -69.43%516K | -69.43%516K | 63.78%2.35M | 49.09%2.22M | 26.35%1.69M | 26.35%1.69M | 159.25%1.25M |
| Current accrued expenses | --3.12M | 1.72%2.55M | 7.49%3.4M | 1.33%3.42M | 1.33%3.42M | 46.20%2.5M | 153.53%3.16M | 508.65%3.38M | 508.65%3.38M | 304.55%2.58M |
| Current debt and capital lease obligation | --112K | 0.93%109K | -4.35%110K | -38.21%76K | -38.21%76K | -18.18%108K | -0.86%115K | 16.04%123K | 16.04%123K | 106.56%126K |
| -Current capital lease obligation | --112K | 0.93%109K | -4.35%110K | -38.21%76K | -38.21%76K | -18.18%108K | -0.86%115K | 16.04%123K | 16.04%123K | 106.56%126K |
| Current liabilities | --4.35M | -36.88%4.31M | -37.14%4.4M | -28.32%4.84M | -28.32%4.84M | 55.33%6.83M | 98.95%7M | 154.68%6.75M | 154.68%6.75M | 236.01%5.48M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --230K | 660.61%251K | 351.61%280K | 247.25%316K | 247.25%316K | -77.70%33K | -69.46%62K | -61.60%91K | -61.60%91K | -60.40%118K |
| -Long term capital lease obligation | --230K | 660.61%251K | 351.61%280K | 247.25%316K | 247.25%316K | -77.70%33K | -69.46%62K | -61.60%91K | -61.60%91K | -60.40%118K |
| Total non current liabilities | --230K | 660.61%251K | 351.61%280K | 247.25%316K | 247.25%316K | -77.70%33K | -69.46%62K | -61.60%91K | -61.60%91K | -60.40%118K |
| Total liabilities | --4.58M | -33.52%4.56M | -33.73%4.68M | -24.65%5.15M | -24.65%5.15M | 50.99%6.86M | 89.76%7.06M | 136.92%6.84M | 136.92%6.84M | 190.20%5.6M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | ---99.66M | -19.41%-96.18M | -27.52%-92.55M | -38.95%-88.68M | -38.95%-88.68M | -69.68%-80.54M | -75.82%-72.57M | -76.43%-63.82M | -76.43%-63.82M | -78.40%-55.55M |
| Paid-in capital | --115.98M | 2.32%106.16M | 4.06%105.88M | 4.36%105.68M | 4.36%105.68M | 4.48%103.75M | 3.28%101.74M | 3.71%101.26M | 3.71%101.26M | 3.64%100.17M |
| Less: Treasury stock | ---- | ---- | ---- | --0 | --0 | --1.22M | --1.22M | --1.22M | --1.22M | ---- |
| Total stockholders'equity | --16.32M | -54.60%9.99M | -52.31%13.33M | -53.08%17M | -53.08%17M | -57.58%21.99M | -51.16%27.95M | -41.07%36.22M | -41.07%36.22M | -31.88%44.62M |
| Total equity | --16.32M | -54.60%9.99M | -52.31%13.33M | -53.08%17M | -53.08%17M | -57.58%21.99M | -51.16%27.95M | -41.07%36.22M | -41.07%36.22M | -31.88%44.62M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.